Skip to content

Cingulate Inc.

CING Nasdaq SEC CIK 1862150

Follow Cingulate Weekly email: filings, results, news

News

1 story filed under Cingulate

Cingulate publishes pharmacokinetic study on ADHD drug candidate

Markets 44 d ago

Profile

Headquarters: KANSAS CITY, KS, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 1 story clustered from the RSS aggregator